Cramer's 'Mad Money' Recap: Checking My List
Cramer said that Alexion's primary drug, Soliris, is the gift that keeps on giving. It currently treats ultra-rare blood conditions to the tune of $1.5 billion in sales, but is also in testing to treat numerous other conditions which could add another $2.5 billion in sales. Shares of Alexion are down 19 points from their highs after a disappointing quarter in October and the company receiving an FDA warning letter last week.
Cramer said he's not worried about the quarter because the analysts clearly got ahead of themselves, and the warning letter simply means the company will need to refine how it manufactures Soliris a little further. Trading at just 28 times earnings with a 33% growth rate, Cramer said that Alexion remains a bargain.
Then there's BioMarin, a company with a $7.7 billion market cap but no earnings. Cramer said this company makes enzyme replacement therapies to treat a host of rare genetic diseases. Like Alexion, it has a robust pipeline of new drugs and new indications for its existing stable. Shares of BioMarin are just off their highs and Cramer said he remains a buyer of this biotech, too.
Investors looking for this quarter's top performers might want to take a look at last quarter's top performers, said Cramer, who ran through the top 10 stocks from the S&P 500.Cramer said Netflix (NFLX) tops the list and is likely to have an encore performance this quarter as its original content and other media deals continue to make it must-have entertainment. Cramer said the next three winners from last quarter -- Best Buy (BBY), Hewlett-Packard (HPQ) and H&R Block (HRB) -- aren't likely to do well this quarter as they've run out of gas. He was more upbeat on Micron Technology (MU), however, because consolidation has made it one of only three DRAM memory suppliers, down from seven just two years ago. In the health care group, Cramer said Celgene (CELG) and Tenet Healthcare (THC) both remain favorites. Marathon Petroleum (MRO) and Avon Products (AVP) are both inexpensive. Finally, there's grocer Safeway (SWY), a stock that was up 45% last quarter as that company continues to make a comeback against Whole Foods (WFM). At 11 times earnings, Cramer said, Safeway is a steal.
Lightning RoundIn the Lightning Round, Cramer was bullish on Priceline.com (PCLN), Progenics Pharmaceuticals (PGNX), Alaska Air Group (ALK), US Airways Group (LCC), Hanger (HGR) and eBay (EBAY).
Which Is Better?Sometimes the right question to ask is not "which is the better stock," but "which is the better stock... for me." That was the question Cramer was pondering over the weekend after an oil spill made him question whether pipeline operators such as Enbridge (ENB) are better or worse than a company such as American Water Works (AWK), whose CEO appeared on "Mad Money" last week. Both transport liquids via pipes, noted Cramer, but they appeal to different investors. Cramer said investors looking for less risk should certainly chose American Water Works. The company has a lot of room to expand, but when its pipes burst the environmental effects are small. Meanwhile, those looking for more growth should consider Enbridge, the lowest-priced pipeline operator and the largest in the country. Enbridge predicts $35 billion in new investments coming, said Cramer, and the company sports a 2.7% dividend. Enbridge also has terrific earnings visibility.
No Huddle OffenseIn his "No Huddle Offense" segment, Cramer took a quick look at some of last quarter's S&P 500 losers. He said the declines in Cliffs Natural Resources (CLF), Apollo Group (APOL) and Apple (AAPL) continue to weigh on the averages, but those of Akamai (AKAM) and Newfield Exploration (NFX) have presented buying opportunities. To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here. To watch replays of Cramer's video segments, visit the Mad Money page on CNBC. -- Written by Scott Rutt in Washington, D.C. To email Scott about this article, click here: Scott Rutt Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
Check Out Our Best Services for Investors
Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Every recommendation goes through 3 layers of intense scrutinyquantitative, fundamental and technical analysisto maximize profit potential and minimize risk.
Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.